Net Contents
90 Capsule(s)
Serving Size
3 Capsule(s)
Servings Per Container
30
Supplement Form
Capsule
Bar Code (UPC/SKU)
8 10034 44007 5
Product Version
R2.1020
Label Analysis
Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.
Single-ingredient formula listed in Supplement Facts.
Label includes a proprietary blend, so some individual amounts are not itemized.
This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.
Supplement Facts
Serving Size: 3 Capsule(s) · 2 per day
| Ingredient | Amount Per Serving | |
|---|---|---|
| Proprietary Herbal Blend | 1500 mg | — |
| Astragalus root extract | — | — |
| Eleuthero root extract | — | — |
| Asian Ginseng root extract | — | — |
| Schisandra extract | — | — |
| Ligustrum | — | — |
| Hawthorne extract | — | — |
| Licorice root extract | — | — |
Not Present
Other Ingredients
Target Groups
Label Claims
Directions & Suggested Use
Suggested/Recommended/Usage/Directions
Suggested Use: Three capsules, 2 times per day between meals, or as recommended by your health care practitioner.
Warnings & Precautions
Precautions re: All Other
Notice: As with any dietary supplement, do not take without first consulting your health care practitioner, especially if you are pregnant, nursing, or are under medical supervision for any reason.
Precautions re: Pregnant or Nursing or Prescription Medications
Notice: As with any dietary supplement, do not take without first consulting your health care practitioner, especially if you are pregnant, nursing, or are under medical supervision for any reason.
Precautions re: Children
Keep out of reach of children.
Formulation
Formulation re: Other
Made in the U.S.A.
Formula re: Contains
Astragalus 8 - Si Jun Zi Tang
FDA Statements
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA Statement of Identity
Herbal Supplement
Other Label Statements
General Statements: All Other Content
Chinese Traditional Formulas
General Statements: All Other Content
Combining Modern Research and Ancient Wisdom
Manufacturer & Distributor
Manufacturer
Health Concerns
Springville, Utah
1 (800) 233-9355
Market Reference
Astra 8 Health Concerns
PureFormulas.com4.9(16)$27.90Health Concerns - Astra 8 90 caps
Vita Living4.9(16)$27.90Health Concerns Astra 8 Capsules | TENSnet.com 90 Capsules
TensNet.com4.9(16)$22.32Health Concerns - Astra 8 270 caps
Vita Living4.9(16)$69.90Astra Isatis Health Concerns
Supplement First4.9(11)$31.90Astra Essence Health Concerns
DrAlexRinehart.com5.0(23)$29.90Astra C Health Concerns
Village Green Apothecary4.9(18)$23.92Health Concerns Astra 18 Diet
PureFormulas.com4.3(6)$39.90
Where to Buy Locally
Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.
Showing representative supplement & health retailers — search above for stores in your area.
Pure Nutrition | Vitamins, Supplements, CBD & Peptides
4.3 (53)Vitamin & supplements store
1450 W Horizon Ridge Pkwy #303, Henderson, NV 89012, United States
Research & Studies
Thymus ad astra, or spaceflight-induced thymic involution
W Muramatsu, M Maryanovich, T Akiyama… - Frontiers in …, 2025 - frontiersin.org
… health concern and impairing their performance (61–67). Additional evidence of adverse immunological manifestations occurring during either short- or long-duration spaceflight …
20254 citationsImpact of the Astra Zeneca COVID‐19 vaccine on an emergency department
J Deans, B Burns, W Portas, C Hannah… - Emergency Medicine …, 2025 - Wiley Online Library
… Subsequently, on 8 April 2021 ATAGI released guidance advising individuals under the … healthcare system. The phenomenon of patients presenting to the EDs with AZ vaccine concern …
20251 citationsHealth-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population
A Miners, A Phillips, N Kreif, A Rodger, A Speakman… - The lancet HIV, 2014 - thelancet.com
… We merged two UK cross-sectional surveys: the ASTRA study, which recruited participants … only in ASTRA). Second, the possibility of endogeneity was a particular concern. That is, …
2014440 citationsThe phytoestrogen genistein induces thymic and immune changes: a human health concern?
S Yellayi, A Naaz, MA Szewczykowski, T Sato… - Proceedings of the …, 2002 - pnas.org
… rodents induces thymic atrophy and immune suppression (8, 9). Despite genistein's affinity for … We determined whether the anti-estrogen ICI 182,780 (Astra-Zeneca, Macclesfield, UK) …
2002353 citationsSocio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
L Burch, C Smith, J Anderson, L Sherr, A Rodger… - J Int AIDS …, 2014 - Wiley Online Library
… data from ASTRA, a crosssectional, questionnaire study of! 3000 individuals from 8 clinics in … This is of concern regarding their own health, as well as risk for sexual partners and …
201424 citationsAssessing cost savings when unnecessary utilization of laboratory tests can be abolished
P Winkel, BE Statland - American Journal of Clinical Pathology, 1984 - academic.oup.com
… ready to be assayed by the analyst using either the ASTRA-8 or the RA-1000 system. The direct … We suggest that computer vendors be made aware of our concerns to audit laboratory …
198425 citations
Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2022-01-22. DSLD Label ID: 259156. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.



